United States · Venture startup
4 rounds we have observed, with the 11 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$74Mraised across 4 rounds since 2007, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $8.1M sold, first sale Jun 2014
Reported by masshightech.comSEC filing: $1.9M sold, first sale Oct 2012
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
This firm lists Mitralign as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Mitralign's investors include Johnson & Johnson Development Corporation (JJDC), Oxford Bioscience Partners, Medtronic, Triathlon Medical Venture Partners and Forbion Capital Partners, and 6 more on record.
Mitralign has raised $74M across 4 rounds since 2007.
Mitralign's most recent round was a Venture of $8.0M in Jun 2014.
Mitralign's largest round on record is $35M (Series D), in May 2012.
Mitralign's first round on record, in Dec 2007, was backed by Johnson & Johnson Development Corporation (JJDC), Oxford Bioscience Partners and Giza Venture Capital and 5 others.
Mitralign's latest named round is a Venture, in Jun 2014.
Mitralign is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
